vs

Side-by-side financial comparison of Prelude Therapeutics Inc (PRLD) and Sunlands Technology Group (STG). Click either name above to swap in a different company.

Sunlands Technology Group is the larger business by last-quarter revenue ($10.1M vs $6.5M, roughly 1.6× Prelude Therapeutics Inc). Sunlands Technology Group runs the higher net margin — 24.0% vs -303.5%, a 327.4% gap on every dollar of revenue.

STG Partners, LLC (STG) is an American private equity firm and based in Menlo Park, California. Its predecessor, Symphony Technology Group ("Symphony") was founded in 2002 by Romesh Wadhwani, William Chisholm, and Bryan Taylor. In 2017, Symphony was reorganized as STG Partners. As of March 2025, STG Partners managed approximately $12 billion in 19 pooled investment vehicle for its clients. The firm itself has less than one billion dollars in assets.

PRLD vs STG — Head-to-Head

Bigger by revenue
STG
STG
1.6× larger
STG
$10.1M
$6.5M
PRLD
Higher net margin
STG
STG
327.4% more per $
STG
24.0%
-303.5%
PRLD

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
PRLD
PRLD
STG
STG
Revenue
$6.5M
$10.1M
Net Profit
$-19.7M
$2.4M
Gross Margin
88.5%
Operating Margin
-314.1%
26.5%
Net Margin
-303.5%
24.0%
Revenue YoY
116.7%
Net Profit YoY
38.9%
EPS (diluted)
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRLD
PRLD
STG
STG
Q3 25
$6.5M
$10.1M
Q2 25
$9.3M
Q4 24
$9.7M
Q3 24
$3.0M
Q2 24
$10.0M
Q3 23
$9.9M
Q2 23
$10.0M
Net Profit
PRLD
PRLD
STG
STG
Q3 25
$-19.7M
$2.4M
Q2 25
$1.4M
Q4 24
$1.8M
Q3 24
$-32.3M
Q2 24
$2.2M
Q3 23
$2.5M
Q2 23
$3.3M
Gross Margin
PRLD
PRLD
STG
STG
Q3 25
88.5%
Q2 25
85.2%
Q4 24
83.3%
Q3 24
Q2 24
85.2%
Q3 23
87.8%
Q2 23
88.7%
Operating Margin
PRLD
PRLD
STG
STG
Q3 25
-314.1%
26.5%
Q2 25
15.2%
Q4 24
13.4%
Q3 24
-1145.9%
Q2 24
Q3 23
23.3%
Q2 23
29.6%
Net Margin
PRLD
PRLD
STG
STG
Q3 25
-303.5%
24.0%
Q2 25
15.4%
Q4 24
18.2%
Q3 24
-1075.7%
Q2 24
21.5%
Q3 23
25.1%
Q2 23
33.0%
EPS (diluted)
PRLD
PRLD
STG
STG
Q3 25
$-0.26
Q2 25
Q4 24
Q3 24
$-0.43
Q2 24
$0.31
Q3 23
Q2 23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRLD
PRLD
STG
STG
Cash + ST InvestmentsLiquidity on hand
$55.0M
$15.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$58.5M
$17.7M
Total Assets
$94.8M
$41.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRLD
PRLD
STG
STG
Q3 25
$55.0M
$15.1M
Q2 25
Q4 24
$15.6M
Q3 24
$153.6M
Q2 24
$18.7M
Q3 23
$16.5M
Q2 23
Total Debt
PRLD
PRLD
STG
STG
Q3 25
Q2 25
Q4 24
$1.5M
Q3 24
Q2 24
$1.8M
Q3 23
$2.2M
Q2 23
Stockholders' Equity
PRLD
PRLD
STG
STG
Q3 25
$58.5M
$17.7M
Q2 25
$12.6M
Q4 24
$10.7M
Q3 24
$156.4M
Q2 24
$7.6M
Q3 23
$2.5M
Q2 23
Total Assets
PRLD
PRLD
STG
STG
Q3 25
$94.8M
$41.2M
Q2 25
$40.3M
Q4 24
$42.4M
Q3 24
$197.2M
Q2 24
$41.3M
Q3 23
$40.0M
Q2 23
Debt / Equity
PRLD
PRLD
STG
STG
Q3 25
Q2 25
Q4 24
0.14×
Q3 24
Q2 24
0.24×
Q3 23
0.86×
Q2 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRLD
PRLD
STG
STG
Operating Cash FlowLast quarter
$-19.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRLD
PRLD
STG
STG
Q3 25
$-19.1M
Q2 25
Q4 24
Q3 24
$-27.3M
Q2 24
Q3 23
Q2 23
Free Cash Flow
PRLD
PRLD
STG
STG
Q3 25
Q2 25
Q4 24
Q3 24
$-27.4M
Q2 24
Q3 23
Q2 23
FCF Margin
PRLD
PRLD
STG
STG
Q3 25
Q2 25
Q4 24
Q3 24
-912.0%
Q2 24
Q3 23
Q2 23
Capex Intensity
PRLD
PRLD
STG
STG
Q3 25
0.0%
Q2 25
Q4 24
Q3 24
2.1%
Q2 24
Q3 23
Q2 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons